"Quick-starting" of a New Combined Hormonal Contraceptive Pills, 15 mg Estetrol/3 mg Drospirenone VS 20 mcg Ethinylestradiol/75 mcg Gestodene Focusing on Ovulation Inhibition

NCT06396221 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Ultrasound Finding: Ovulation Inhibition, Ovarian Activities
Cervical Mucus
Serum Hormonal Profile

Interventions

DRUG: Estetrol 15 mg/Drospirenone 3 mg (24/4)
DRUG: Ethinylestradiol (EE) 20 mcg/Gestodene 75 mcg (21/7)

Sponsor

Chulalongkorn University